The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer
Pellegrino, Nicole E, Guven, Arcan, Gray, Kayleigh, Shah, Punit, Kasture, Gargi, Nastke, Maria-Dorothea, Thakurta, Anjan, Gesta, Stephane, Vishnudas, Vivek K, Narain, Niven R, Kiebish, Michael A
Published in International journal of molecular sciences (23.03.2022)
Published in International journal of molecular sciences (23.03.2022)
Get full text
Journal Article
Human CD4+ T Cell Response to Human Herpesvirus 6
NASTKE, Maria-D, BECERRA, Aniuska, LIUSONG YIN, DOMINGUEZ-AMOROCHO, Omar, GIBSON, Laura, STERN, Lawrence J, CALVO-CALLE, J. Mauricio
Published in Journal of Virology (01.05.2012)
Published in Journal of Virology (01.05.2012)
Get full text
Journal Article
Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis
Thiel, Austin, Yavanian, Gregory, Nastke, Maria-Dorothea, Morales, Peter, Kouris, Nicholas A., Kimbrel, Erin A., Lanza, Robert
Published in Scientific reports (02.12.2015)
Published in Scientific reports (02.12.2015)
Get full text
Journal Article
Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway
Bommarito, Davide, Martin, Allison, Forcade, Edouard, Nastke, Maria-Dorothea, Ritz, Jerome, Bellucci, Roberto
Published in Cancer Immunology, Immunotherapy (01.03.2016)
Published in Cancer Immunology, Immunotherapy (01.03.2016)
Get full text
Journal Article
An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma
Clement, Cristina C, Cannizzo, Elvira S, Nastke, Maria-Dorothea, Sahu, Ranjit, Olszewski, Waldemar, Miller, Norman E, Stern, Lawrence J, Santambrogio, Laura
Published in PloS one (26.03.2010)
Published in PloS one (26.03.2010)
Get full text
Journal Article
Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection
Calvo-Calle, J Mauricio, Strug, Iwona, Nastke, Maria-Dorothea, Baker, Stephen P, Stern, Lawrence J
Published in PLoS pathogens (01.10.2007)
Published in PLoS pathogens (01.10.2007)
Get full text
Journal Article
Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas
DENGJEL, Jörn, NASTKE, Maria-Dorothea, HENNENLOTTER, Jorg, WERNET, Dorothee, STENZL, Arnulf, RAMMENSEE, Hans-Georg, KLINGEL, Karin, STEVANOVIC, Stefan, GOUTTEFANGEAS, Cécile, GITSIOUDIS, Gitsios, SCHOOR, Oliver, ALTENBEREND, Florian, MÜLLER, Margret, KRÄMER, Björn, MISSIOU, Anna, SAUTER, Martina
Published in Clinical cancer research (15.07.2006)
Published in Clinical cancer research (15.07.2006)
Get full text
Journal Article
Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers
GUCKEL, Brigitte, RENTZSCH, Christine, NASTKE, Maria-Dorothea, MARME, Alexander, GRUBER, Ines, STEVANOVIC, Stefan, KAYSER, Simone, WALLWIENER, Diethelm
Published in Journal of cancer research and clinical oncology (01.04.2006)
Published in Journal of cancer research and clinical oncology (01.04.2006)
Get full text
Journal Article
SNEP: SNP-derived epitope prediction program for minor H antigens
Schuler, Mathias M, Dönnes, Pierre, Nastke, Maria-Dorothea, Kohlbacher, Oliver, Rammensee, Hans-Georg, Stevanovic, Stefan
Published in Immunogenetics (New York) (01.12.2005)
Published in Immunogenetics (New York) (01.12.2005)
Get full text
Journal Article
Abstract 6518: BPM 31510: Targeting the tumor microenvironment (TME) via mitochondrial-mediated ROS production
Gesta, Stephane, Nastke, Maria D., Nagpal, Seema, Recht, Lawrence, Kiebish, Michael A., Narain, Niven R., Modur, Vijay R.
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 2943: Interrogative Biology® platform identifies a novel target in the ubiquitin pathway and its utility in cancer is supported by small molecule modulators
Gesta, Stephane, Sharma, Shefali, Sundararajan, Pragalath, Huang, Mingshu, Gray, Kayleigh, Nastke, Maria, Guven, Arcan, Diers, Anne, Kazerounian, Shiva, Hazarika, Suwagmani, Grund, Eric M., Vishnudas, Vivek K., Narain, Niven R., Sarangarajan, Rangaprasad
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 703: The anti-cancer drug BPM 31510 elicits immune-modulatory effects through regulation of IL-10
Dowal, Louisa, Nastke, Maria D., Gaur, Nidhi, Singh, Richa, Fowler, Samantha, Jayashankar, Shyamali, Diers, Anne R., Gesta, Stephane, Vishnudas, Vivek, Narain, Niven R., Sarangarajan, Rangaprasad
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 5576: BPM 31510, a clinical stage candidate demonstrates potent anti-tumor effect in an immune-competent syngeneic pancreatic cancer model
Kazerounian, Shiva, Sarma, Aishwarya, Gaur, Nidhi, Nastke, Maria D., Dadali, Tulin, Diers, Anne R., Gesta, Stephane, Vishnudas, Vivek K., Sarangarajan, Rangaprasad, Narain, Niven R.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract 1680: BPM31510, an anti-cancer agent selectively causes activation and proliferation of T cells, demonstrating potential utility in an immune-oncology setting
Nastke, Maria-D, Gaur, Nidhi, Dowal, Louisa, Fowler, Samantha, Diers, Anne, Gesta, Stephane, Vishnudas, Vivek K., Narain, Niven R., Sarangarajan, Rangaprasad
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract 4724: Immuno-modulatory activity of BPM31510 supports T cell viability, proliferation, and function while reversing early signs of exhaustion
Nastke, Maria, Kazerounian, Shiva, Gaur, Nidhi, Jayashankar, Shyamali, Linsenmayer, David, Spencer, Carrie, Nambiar, Arun, Sarma, Aishwarya, Diers, Anne R., Gesta, Stephane, Vishnudas, Vivek, Sukhatme, Vikas P., Narain, Niven R., Sarangarajan, Rangaprasad
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 4694: In charge: Targeting neddylation of UBE2M for anticancer therapy
Batrouni, Alex G., Matson, Jacob P., Mota, Andressa L., Ravi, Archna, O'Hara, Marcus, Smith, Micholas D., Smith, Jeremy C., Vishnudas, Vivek K., Thakurta, Anjan, Gesta, Stephane, Nastke, Maria D.
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 1663: Development of a novel oral microtubule targeting agent with pan-cancer efficacy
Nastke, Maria-Dorothea, Matson, Jacob, Mota, Andressa, Ravi, Archna, Batrouni, Alex, O'Hara, Marcus, Kazerounian, Shiva, Guven, Arcan, Pellegrino, Nicole, Grover, Kashni, Gray, Kayleigh, Diers, Anne, Kiebish, Michael, Vishnudas, Vivek, Gesta, Stephane
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 5321: BRG399: A novel potent small molecule modulator of UBE2K for the treatment of various cancers
Nastke, Maria-Dorothea, Permatteo, Marisa, Sundararajan, Pragalath, Sharma, Shefali, Matson, Jacob, Gray, Kaleigh, Guven, Arcan, Kazerounian, Shiva, Diers, Anne, Sarangarajan, Rangaprasad, Narain, Niven R., Vishnudas, Vivek K., Gesta, Stephane
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 5320: BRG399, a small molecule modulator of UBE2K demonstrated dose-dependent anti-cancer efficacy in an in vivo model for gastric cancer
Kazerounian, Shiva, O'Hara, Mollie, Guven, Arcan, Grover, Kashni, Pellegrino, Nicole, Gray, Kayleigh, Bruce, Can, Miller, Gregory M., Nastke, Maria-Dorothea, Kiebish, Michael A., Grund, Eric M., Sarangarajan, Rangaprasad, Narain, Niven R., Gesta, Stephane, Vishnudas, Vivek K.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article